Revolution Medicines, Inc. (RVMD)
177.96
-11.30
(-5.97%)
USD |
NASDAQ |
Oct 16, 16:00
177.47
-0.49
(-0.28%)
After-Hours: 20:00
Revolution Medicines Research and Development Expense (Annual) : 978.68M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 978.68M |
| December 31, 2024 | 584.60M |
| December 31, 2023 | 417.03M |
| December 31, 2022 | 248.03M |
| December 31, 2021 | 182.80M |
| Date | Value |
|---|---|
| December 31, 2020 | 128.57M |
| December 31, 2019 | 91.16M |
| December 31, 2018 | 51.08M |
| December 31, 2017 | 26.59M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Moderna, Inc. | 2.917B |
| Arrowhead Pharmaceuticals, Inc. | 585.26M |
| Intellia Therapeutics, Inc. | 379.09M |
| Oncolytics Biotech, Inc. | 13.31M |
| Twist Bioscience Corp. | 80.28M |